Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 139Carcinoma, Intraductal, Noninfiltrating 8Neoplasm Metastasis 6Breast Carcinoma In Situ 5Breast Neoplasms, Male 4Breast Diseases 4Arthralgia 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Endometrial Neoplasms 3Advanced Breast Cancer 3Neoplasms 2Breast Cancer Metastatic 2Solid Tumor 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Seizures 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Osteoporosis 1Obesity 1Muscle Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Locoregional Recurrence 1Invasive Breast Cancer 1Hypogonadism 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1

Interventions

testosterone undecanoate 3Testosterone 3testosterone 17 beta-cypionate 1Triptorelin Pamoate 1Testosterone Propionate 1Tamoxifen 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Orchiectomy 1Observation 1Methyltestosterone 1Mental Status and Dementia Tests 1Gonadotropin-Releasing Hormone 1Gels 1Drug Evaluation 1Clomiphene 1Castor Oil 1Blood Specimen Collection 1Anastrozole 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypogonadism × Anastrozole × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡